Ultima Genomics, Inc., a pioneering force in the genomics industry, is headquartered in the United States. Founded in 2020, the company has rapidly established itself as a leader in next-generation sequencing technology, focusing on making genomic data more accessible and affordable. With a commitment to innovation, Ultima Genomics offers unique sequencing solutions that significantly reduce costs while enhancing throughput and accuracy. Their flagship products are designed to empower researchers and clinicians, facilitating breakthroughs in personalised medicine and genomic research. Recognised for its cutting-edge advancements, Ultima Genomics is positioned at the forefront of the genomics market, driving transformative changes in how genomic information is utilised across various sectors.
How does Ultima Genomics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Ultima Genomics, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ultima Genomics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Ultima Genomics may still be in the early stages of developing its climate commitments or reporting frameworks. As the company operates within the biotechnology sector, it is essential for Ultima Genomics to establish clear climate strategies and reduction initiatives to align with industry standards and expectations. The absence of emissions data and reduction targets may limit its ability to demonstrate environmental responsibility and commitment to sustainability.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ultima Genomics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
